Article
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 2 May 2022
Seeber Andreas, Battaglin Francesca, Zimmer Kai, Kocher Florian, Baca Yasmine, Xiu Joanne, Spizzo Gilbert, Novotny-Diermayr Veronica, Rieder Dietmar, Puccini Alberto, Swensen Jeff, Ellis Michelle, Goldberg Richard M, Grothey Axel, Shields Anthony F, Marshall John L, Weinberg Benjamin A, Sackstein Paul E, Lim Kiat Hon, Tan Gek San, Nabhan Chadi, Korn W Michael, Amann Arno, Trajanoski Zlatko, Berger Martin D, Lou Emil, Wolf Dominik, Lenz Heinz-Josef
Abstract excerpt
PURPOSE: Gene fusions involving R-spondin (RSPOfp) and RNF43 mutations have been shown to drive Wnt-dependent tumor initiation in colorectal cancer. Herein, we aimed to characterize the molecular features of RSPOfp/RNF43 mutated (mut) compared with wild-type (WT) colorectal cancers to gain insights into potential rationales for therapeutic strategies. EXPERIMENTAL DESIGN: A discovery cohort was classified for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
